Inflammatory (B) symptoms are independent predictors of myelosuppression from chemotherapy in Non-Hodgkin Lymphoma (NHL) patients – analysis of data from a British National Lymphoma Investigation phase III trial comparing CHOP to PMitCEBO

BACKGROUND: Toxicity from chemotherapy is highly variable, unpredictable and results in substantial morbidity and increased healthcare costs. New predictors of toxicity are required to improve the safety and efficacy of chemotherapy. Inflammatory or B symptoms in lymphoma are associated with elevate...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Rohini, Cunningham, David, Smith, Paul, Robertson, Graham, Dent, Owen, Clarke, Stephen J
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689869/
https://www.ncbi.nlm.nih.gov/pubmed/19450285
http://dx.doi.org/10.1186/1471-2407-9-153

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689869/
https://www.ncbi.nlm.nih.gov/pubmed/19450285
http://dx.doi.org/10.1186/1471-2407-9-153

Ejemplares similares